Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours; the GREPONET-2 study.

Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvalho LFDP, Bezerra ROF, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Baudin E, Sundin A, Costa FP, Pavel M, Dromain C.

Clin Cancer Res. 2019 Aug 2. pii: clincanres.0963.2019. doi: 10.1158/1078-0432.CCR-19-0963. [Epub ahead of print]

PMID:
31375514
2.

Pulmonary lymphangitic carcinomatosis: diagnostic performance of HRCT and 18F-FDG-PET/CT in correlation to clinical pathologic outcome.

Jreige M, Dunet V, Letovanec I, Prior JO, Meuli RA, Beigelman-Aubry C, Schaefer N.

J Nucl Med. 2019 Jun 21. pii: jnumed.119.229575. doi: 10.2967/jnumed.119.229575. [Epub ahead of print]

PMID:
31227574
3.

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Jreige M, Letovanec I, Chaba K, Renaud S, Rusakiewicz S, Cristina V, Peters S, Krueger T, de Leval L, Kandalaft LE, Nicod-Lalonde M, Romero P, Prior JO, Coukos G, Schaefer N.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1859-1868. doi: 10.1007/s00259-019-04348-x. Epub 2019 Jun 18.

PMID:
31214790
4.

Diagnostic Performance of PET or PET/CT Using 18F-FDG Labeled White Blood Cells in Infectious Diseases: A Systematic Review and a Bivariate Meta-Analysis.

Meyer M, Testart N, Jreige M, Kamani C, Moshebah M, Muoio B, Nicod-Lalonde M, Schaefer N, Giovanella L, Prior JO, Treglia G.

Diagnostics (Basel). 2019 Jun 15;9(2). pii: E60. doi: 10.3390/diagnostics9020060. Review.

5.

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice.

Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K, Amato E, Auditore L, Coukos G, Stabin M, Schaefer N, Viertl D, Prior JO.

EJNMMI Res. 2019 Jun 11;9(1):53. doi: 10.1186/s13550-019-0524-7.

6.

Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.

Degrauwe N, Hocquelet A, Digklia A, Schaefer N, Denys A, Duran R.

Front Pharmacol. 2019 May 9;10:450. doi: 10.3389/fphar.2019.00450. eCollection 2019. Review.

7.

First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE.

Savovic T, Prior JO, Nicod-Lalonde M, Bressoud A, Roux S, Schaefer N, Meyer M.

Med Oncol. 2019 Mar 27;36(5):41. doi: 10.1007/s12032-019-1266-0.

PMID:
30919094
8.

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Franca Bezerra RO, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Sundin A, Costa F, Pavel M, Dromain C; Knowledge Network.

Oncologist. 2019 Mar 25. pii: theoncologist.2018-0672. doi: 10.1634/theoncologist.2018-0672. [Epub ahead of print]

PMID:
30910869
9.

Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.

Blanc-Durand P, Van Der Gucht A, Verger A, Langen KJ, Dunet V, Bloch J, Brouland JP, Nicod-Lalonde M, Schaefer N, Prior JO.

PLoS One. 2018 Jun 28;13(6):e0199379. doi: 10.1371/journal.pone.0199379. eCollection 2018.

10.

Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.

Blanc-Durand P, Van Der Gucht A, Schaefer N, Itti E, Prior JO.

PLoS One. 2018 Apr 13;13(4):e0195798. doi: 10.1371/journal.pone.0195798. eCollection 2018.

11.

Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma.

Blanc-Durand P, Van Der Gucht A, Jreige M, Nicod-Lalonde M, Silva-Monteiro M, Prior JO, Denys A, Depeursinge A, Schaefer N.

Oncotarget. 2017 Dec 19;9(4):4549-4558. doi: 10.18632/oncotarget.23423. eCollection 2018 Jan 12.

12.

Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma.

Van Der Gucht A, Maged Z, Burruni R, Barras JL, Schaefer N.

Clin Nucl Med. 2018 Jan;43(1):41-43. doi: 10.1097/RLU.0000000000001905.

PMID:
29166332
13.

18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma.

Jreige M, Mitsakis P, Van Der Gucht A, Pomoni A, Silva-Monteiro M, Gnesin S, Boubaker A, Nicod-Lalonde M, Duran R, Prior JO, Denys A, Schaefer N.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1215-1222. doi: 10.1007/s00259-017-3653-0. Epub 2017 Feb 23.

PMID:
28233086
14.

Resin Versus Glass Microspheres for 90Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry.

Van Der Gucht A, Jreige M, Denys A, Blanc-Durand P, Boubaker A, Pomoni A, Mitsakis P, Silva-Monteiro M, Gnesin S, Lalonde MN, Duran R, Prior JO, Schaefer N.

J Nucl Med. 2017 Aug;58(8):1334-1340. doi: 10.2967/jnumed.116.184713. Epub 2017 Jan 12.

15.

[Cardiac sarcoidosis: seven keypoints to remind in order to avoid misdiagnosis].

Porretta AP, Van der Gucht A, Bisch L, Mitsakis P, Pomoni A, Allenbach G, Lalonde MN, Schaefer N, Buss G, Prior JO, Pruvot É.

Rev Med Suisse. 2016 May 25;12(520):1035-6, 1038-41. Review. French.

PMID:
27424343
16.

Arterial Therapies of Non-Colorectal Liver Metastases.

Puippe G, Pfammatter T, Schaefer N.

Viszeralmedizin. 2015 Dec;31(6):414-22. doi: 10.1159/000441689. Epub 2015 Dec 1. Review.

17.

68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?

Sommerauer M, Burkhardt JK, Frontzek K, Rushing E, Buck A, Krayenbuehl N, Weller M, Schaefer N, Kuhn FP.

Neuro Oncol. 2016 Jul;18(7):1021-7. doi: 10.1093/neuonc/now001. Epub 2016 Feb 9.

18.

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.

Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P.

BMC Cancer. 2015 Dec 23;15:1002. doi: 10.1186/s12885-015-2009-z.

19.

Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.

Reiner CS, Gordic S, Puippe G, Morsbach F, Wurnig M, Schaefer N, Veit-Haibach P, Pfammatter T, Alkadhi H.

Cardiovasc Intervent Radiol. 2016 Mar;39(3):400-8. doi: 10.1007/s00270-015-1185-1. Epub 2015 Jul 28.

PMID:
26216725
20.

Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.

Sah BR, Burger IA, Schibli R, Friebe M, Dinkelborg L, Graham K, Borkowski S, Bacher-Stier C, Valencia R, Srinivasan A, Hany TF, Mu L, Wild PJ, Schaefer NG.

J Nucl Med. 2015 Mar;56(3):372-8. doi: 10.2967/jnumed.114.147116. Epub 2015 Feb 12.

Supplemental Content

Loading ...
Support Center